In AD, the severity of tau pathology, assessed according to the Braak staging for NFTs1, is a stronger correlate and predictor of cognitive outcomes than amyloid beta (Aβ) plaques, another neuropathological hallmark of AD7–11. Here, MAPT is linked to Alzheimer disease.